Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07120503 · ClinicalTrials.gov registry record · Phase 2
Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma
A Phase 2 study of Asthma (Diagnosis), sponsored by Windward Bio.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 136
- Enrollment target
- 20
- Study locations
NCT07120503 is a Phase 2 study of Asthma (Diagnosis) that is actively recruiting participants, run by Windward Bio. The registered enrollment target is 136 participants. The trial reports 20 study locations across 12 states.
The verdict
NCT07120503, a Phase 2 study of Asthma (Diagnosis), is actively recruiting participants, sponsored by Windward Bio.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 136 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate or severe asthma. WIN378 blocks the action of a protein called TSLP which causes inflammation in the lung and may contribute to your asthma control and symptoms. The study will test how doses of WIN378 are handled by your body (pharmacokinetics) and assess the safety of the medicine and will assess markers of asthma inflammation in your breath and in your blood, lung function and asthma control (pharmacodynamics).
Conditions Studied
Interventions
- DRUG Placebo
- DRUG WIN378
Study Locations (20)
Texas
- WB Contracted Clinical Research Site - Austin
- WB Contracted Clinical Research Site - El Paso
- WB Contracted Clinical Research Site - McKinney
- WB Contracted Clinical Research Site - San Antonio
- WB Contracted Clinical Research Site - Tyler
California
- WB Contracted Clinical Research Site - Los Angeles
- WB Contracted Clinical Research Site - San Jose
Florida
- WB Contracted Clinical Research Site - Melbourne
- WB Contracted Clinical Research Site - Miami
South Carolina
- WB Contracted Clinical Research Site - Charleston
- WB Contracted Clinical Research Site - Spartanburg
Buenos Aires F.D.
- WB Contracted Clinical Research Site - Buenos Aires
- WB Contracted Clinical Research Site - Buenos Aires
Maryland
- WB Contracted Clinical Research Site - White Marsh
Minnesota
- WB Contracted Clinical Research Site - Richfield
Missouri
- WB Contracted Clinical Research Site - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2025-07-24 |
| Est. Completion | 2027-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07120503
The ClinicalTrials.gov registry entry for NCT07120503 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Windward Bio, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma (Diagnosis) appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07120503 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Texas, California, Florida.
Frequently Asked Questions
What is clinical trial NCT07120503 about?
NCT07120503 is a clinical study titled "Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma". This study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate or severe asthma. WIN378 blocks the action of a protein called TSLP which causes inflammation in the lung and may contribute to your asthma control and symptoms. The study will test how d...
What is the current status of trial NCT07120503?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 136 participants. The study started on 2025-07-24. Estimated completion is 2027-10.
What conditions does trial NCT07120503 study?
This clinical trial studies the following conditions: Asthma (Diagnosis).
What interventions are being tested in trial NCT07120503?
The interventions under investigation include: Placebo (DRUG), WIN378 (DRUG).
Who is sponsoring clinical trial NCT07120503?
This trial is sponsored by Windward Bio, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07120503 being conducted?
This trial has 20 study locations across California, Florida, Maryland, Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma (Diagnosis)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.